Central - Tenders Closing for a specific Date

Report For Day : 17-Apr-2026

Total Tenders : 2303
Sl.No e-Published Date Bid Submission Closing Date Tender Opening Date Title/Ref.No./Tender Id State Name Corrigendum
331. 24-Mar-2026 05:35 PM 17-Apr-2026 11:00 AM 17-Apr-2026 11:00 AM Gabapentin 300mg Cap/VM261204/107005051 Ministry of Railways --
332. 26-Mar-2026 11:46 AM 17-Apr-2026 11:00 AM 17-Apr-2026 11:00 AM DP 26-27of Acarbose 25mg Tab. & Acarbose 50mg Tab./4M261175/107006580 Ministry of Railways --
333. 05-Apr-2026 06:33 PM 17-Apr-2026 11:00 AM 17-Apr-2026 11:00 AM Injection Doxycycline 100 mg/92265209/107015116 Ministry of Railways --
334. 24-Mar-2026 05:34 PM 17-Apr-2026 11:00 AM 17-Apr-2026 11:00 AM 1)Fluconazole 2mg per ml Infusion 2) Flunarizine 10mg Tab 3) Flunarizine 5mg Tab/VM261192/107005041 Ministry of Railways --
335. 26-Mar-2026 11:30 AM 17-Apr-2026 11:00 AM 17-Apr-2026 11:00 AM SITC of Split AC 1.5 Ton Capacity/86247716B/107006537 Ministry of Railways --
336. 24-Mar-2026 05:34 PM 17-Apr-2026 11:00 AM 17-Apr-2026 11:00 AM 1) Flupentixol 0.5mg and Melitracen 10mg Tab 2) Folic acid 5mg Tab/VM261195/107005045 Ministry of Railways --
337. 04-Apr-2026 06:55 PM 17-Apr-2026 11:00 AM 18-Apr-2026 11:00 AM Repairing of 03 Nos. Rotary Motor ( 02 Nos. LHS and 01 No. RHS)of RECP750 Drill Machine at Nigahi Project./NGH/EXCV/TENDERS/26-27/002/2026_NCL_358024_1 Northern Coalfields Limited --
338. 24-Mar-2026 05:38 PM 17-Apr-2026 11:00 AM 17-Apr-2026 11:00 AM 1) Gliclazide 30mg Tab Modified Release 2) Gliclazide 60mg plus Metformin 500mg SR Tab 3) Gliclazide 60mg SR Tab/VM261206/107005063 Ministry of Railways --
339. 27-Mar-2026 10:25 PM 17-Apr-2026 11:00 AM 17-Apr-2026 11:00 AM 1. T3 Test Kit Biomerieux - 60 Test 2. T4 Test Kit Biomerieux - 60 Test 3. TSH Test Kit Biomerieux - 60 Test/02261041/107008707 Ministry of Railways --
340. 05-Apr-2026 06:51 PM 17-Apr-2026 11:00 AM 17-Apr-2026 11:00 AM Tablet Ramipril 2.5 mg [Tablet Ramipril 2.5 mg ]/92265213/107015121 Ministry of Railways --

Note : For more details and clarifications, please refer to the respective Portal.